NSEUpdates1d ago · 4 Sept 2026, 05:42 pm

Updates

Procter & Gamble Health Limited · PGHL

✦ AI SummaryMgmt Change

Procter & Gamble Health Limited has informed the Exchange about the re-appointment of Mr. S. Madhavan as Independent Director of the Company for a period of five years, effective from November 15, 2026, which has been approved by the shareholders at the 59th Annual General Meeting held on September 3, 2026.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Procter & Gamble Health Limited has informed the Exchange regarding 'This is in reference to our letter dated May 26, 2026, regarding re-appointment of Mr. S.Madhavan as Independent Director of the Company, for a period of five years, with effect fromNovember 15, 2026, subject to the approval of the shareholders of the Company. We are pleasedto inform you that the re-appointment of Mr. S. Madhavan as Independent Director of theCompany has been approved by the shareholders of the Company at its 59th Annual GeneralMeeting ( AGM ) held on September 3, 2026.'.

Attachments (1)

📄

PGHL_04092026173958_PGHLAGMOutcome-_2026.pdf

pdf

Download →
View document text
September 4, 2026 To, To, The Corporate Relations Department The Listing Department The BSE Limited The National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400001. Mumbai – 400051 Ref:- Scrip Code:- 500126 Ref:- Symbol:- PGHL Dear Sir / Madam, Sub: Re-appointment of Mr. S. Madhavan as Independent Director of the Company, for a period of five years, with effect from November 15, 2026 This is in reference to our letter dated May 26, 2026, regarding re-appointment of Mr. S. Madhavan as Independent Director of the Company, for a period of five years, with effect from November 15, 2026, subject to the approval of the shareholders of the Company. We are pleased to inform you that the re-appointment of Mr. S. Madhavan as Independent Director of the Company has been approved by the shareholders of the Company at its 59th Annual General Meeting (“AGM”) held on September 3, 2026. We request you to kindly take the above information on record. Thanking you, Yours faithfully, For Procter & Gamble Health Limited Flavia Machado Authorised Signatory